Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hi-Crush Inc.HCLP · Entity 147827 | Director | August 23, 2018 | August 29, 2018 |
| OmniAb, Inc.OABI · Entity 5294 | 10% owner | June 28, 2024 | July 02, 2024 |
| Organogenesis Holdings Inc.ORGO · Entity 6275 | 10% owner | November 12, 2024 | November 19, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hi-Crush Inc.
Report date August 23, 2018 · Filed August 29, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common UnitsSEC Table I · non-derivative | Direct | 831,596 |
Reported balance
Holding disclosure · report date 2018-08-23 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 831,596 |
| Common UnitsSEC Table I · non-derivative | IndirectBy Dean Family 2015 Trust | 90,540 |
Reported balance
Holding disclosure · report date 2018-08-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 90,540 |
OmniAb, Inc.
Report date June 28, 2024 · Filed July 02, 2024
Jointly reported with Avista Capital Managing Member V, LLC, Avista Capital Partners V GP, L.P., Avista Capital Partners V, L.P., Avista Capital Partners (Offshore) V, L.P., Burgstahler David F, Tamaroff Joshua Alexander
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Notes | 15,992,372 |
Reported balance
After 2024-06-29 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2024-06-29 · Exercise / conversion · Acquired 66,668 · Balance 15,992,372 F17: Represents stock options exercised on a net share settlement basis. Accordingly, the Issuer is delivering an aggregate 7,111 shares of common stock to the Reporting Persons in connection with the option exercises, with no shares being sold externally. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Notes | 15,862,815 |
Reported balance
After 2024-06-29 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2024-06-29 · Tax withholding · Disposed 59,557 · Balance 15,862,815 F18: Represents the number of shares withheld by the Issuer to satisfy (i) the aggregate exercise price for the options and (ii) withholding taxes related to such exercise. No shares were sold by the Reporting Persons to satisfy the exercise price of the stock options. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Notes | 15,855,704 |
Reported balance
Holding disclosure · report date 2024-06-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 15,855,704 F7: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. F8: As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F9: Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectSee Notes | 0 |
Reported balance
After 2024-06-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-06-28 · Disposition to issuer · Disposed 20,000 · Balance 0 F5: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F15: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectSee Notes | 0 |
Reported balance
After 2024-06-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-06-28 · Disposition to issuer · Disposed 35,538 · Balance 0 F4: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F15: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F10: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $4.19 · Expires 2034-06-18 | IndirectSee Notes | 0 |
Reported balance
After 2024-06-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-06-28 · Disposition to issuer · Disposed 40,000 · Balance 0 F16: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F6: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.35 · Expires 2032-12-01 | IndirectSee Notes | 66,668 |
Reported balance
After 2024-06-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-06-28 · Disposition to issuer · Disposed 133,333 · Balance 66,668 F16: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F14: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $4.81 · Expires 2033-06-23 | IndirectSee Notes | 40,000 |
Reported balance
Holding disclosure · report date 2024-06-28 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 40,000 F6: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2027-11-01 | IndirectSee Notes | 11,345,489 |
Reported balance
Holding disclosure · report date 2024-06-28 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 11,345,489 F12: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Agreement and Plan of Merger, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1, 2022. F13: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer").
F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer.
F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any.
F4: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023.
F5: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date.
F6: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date.
F7: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration.
F8: As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement.
F9: Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA).
F10: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024.
F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any.
F12: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Agreement and Plan of Merger, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1, 2022.
F13: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022.
F14: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff.
F15: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer.
F16: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer.
F17: Represents stock options exercised on a net share settlement basis. Accordingly, the Issuer is delivering an aggregate 7,111 shares of common stock to the Reporting Persons in connection with the option exercises, with no shares being sold externally.
F18: Represents the number of shares withheld by the Issuer to satisfy (i) the aggregate exercise price for the options and (ii) withholding taxes related to such exercise. No shares were sold by the Reporting Persons to satisfy the exercise price of the stock options.
Organogenesis Holdings Inc.
Report date November 12, 2024 · Filed November 19, 2024
Jointly reported with Avista Capital Managing Member VI, LLC, Avista Capital Partners VI GP, L.P., Avista Healthcare Partners III, L.P., AHP III Orchestra Holdings, L.P., Burgstahler David F
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 2,178,317 |
Reported balance
Holding disclosure · report date 2024-11-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,178,317 F1: Represents shares of common stock directly held by Thompson Dean. F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. |
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 1,555,704 |
Reported balance
Holding disclosure · report date 2024-11-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,555,704 F2: Represents shares of common stock directly held by David Burgstahler. F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. |
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee Explanation of Responses | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-12 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F4: The Convertible Preferred Stock is convertible at the option of a holder at any time into shares of common stock of the Issuer at an initial implied conversion price of $3.7917 per share; provided, however, the maximum number of shares of common stock issuable upon conversion of the Convertible Preferred Stock prior to receipt by the Issuer of stockholder approval (the "Requisite Stockholder Approval"), as contemplated by Nasdaq listing rules, is an aggregate of 26,502,042 shares of common stock (the "Share Cap"), and until the Requisite Stockholder Approval is obtained, no person or group of persons may beneficially own shares of common stock issuable upon conversion of the Convertible Preferred Stock in an amount greater than 19.99% of the then-outstanding shares of common stock.. The Convertible Preferred Stock has no expiration date. F5: Represents the number of shares of the Issuer's common stock that the Convertible Preferred Stock held by AHP III and AHP III Orchestra is currently convertible into due to the Share Cap. F3: Avista Healthcare Partners III, L.P. ("AHP III") directly owns 65,750 shares of the Issuer's Series A Convertible Preferred Stock, par value $0.0001 per share (the "Convertible Preferred Stock"), and AHP III Orchestra Holdings, L.P. ("AHP III Orchestra") directly owns 64,250 shares of Convertible Preferred Stock. Avista Capital Partners VI GP, L.P. ("ACP VI GP") is the general partner of each of AHP III and AHP III Orchestra, and Avista Capital Managing Member VI, LLC ("Avista Managing Member") is the general partners of ACP VI GP. Thompson Dean and David Burgstahler are the managers of Avista Managing Member. F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock directly held by Thompson Dean.
F2: Represents shares of common stock directly held by David Burgstahler.
F3: Avista Healthcare Partners III, L.P. ("AHP III") directly owns 65,750 shares of the Issuer's Series A Convertible Preferred Stock, par value $0.0001 per share (the "Convertible Preferred Stock"), and AHP III Orchestra Holdings, L.P. ("AHP III Orchestra") directly owns 64,250 shares of Convertible Preferred Stock. Avista Capital Partners VI GP, L.P. ("ACP VI GP") is the general partner of each of AHP III and AHP III Orchestra, and Avista Capital Managing Member VI, LLC ("Avista Managing Member") is the general partners of ACP VI GP. Thompson Dean and David Burgstahler are the managers of Avista Managing Member.
F4: The Convertible Preferred Stock is convertible at the option of a holder at any time into shares of common stock of the Issuer at an initial implied conversion price of $3.7917 per share; provided, however, the maximum number of shares of common stock issuable upon conversion of the Convertible Preferred Stock prior to receipt by the Issuer of stockholder approval (the "Requisite Stockholder Approval"), as contemplated by Nasdaq listing rules, is an aggregate of 26,502,042 shares of common stock (the "Share Cap"), and until the Requisite Stockholder Approval is obtained, no person or group of persons may beneficially own shares of common stock issuable upon conversion of the Convertible Preferred Stock in an amount greater than 19.99% of the then-outstanding shares of common stock.. The Convertible Preferred Stock has no expiration date.
F5: Represents the number of shares of the Issuer's common stock that the Convertible Preferred Stock held by AHP III and AHP III Orchestra is currently convertible into due to the Share Cap.
F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Tax withholdingCommon stock, par value $0.0001 per share | 59,557 | $3.75 | $223,338.75 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · nonDerivative · entry 3 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 15,862,815 F18 · shares: Represents the number of shares withheld by the Issuer to satisfy (i) the aggregate exercise price for the options and (ii) withholding taxes related to such exercise. No shares were sold by the Reporting Persons to satisfy the exercise price of the stock options. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3 · ownership.nature: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 29, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionCommon stock, par value $0.0001 per share | 66,668 | $3.35 | $223,337.80 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · nonDerivative · entry 2 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 15,992,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F17 · shares: Represents stock options exercised on a net share settlement basis. Accordingly, the Issuer is delivering an aggregate 7,111 shares of common stock to the Reporting Persons in connection with the option exercises, with no shares being sold externally. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3 · ownership.nature: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Disposition to issuerStock Options · Derivative | 133,333 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · derivative · entry 8 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 66,668 Underlying: Common stock, par value $0.0001 · 66,668 shares Expires 2032-12-01 F16 · kind: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F14 · derivative.exercise_date: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. F14 · derivative.underlying_shares: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. F14 · balance_after: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. F14 · ownership.nature: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Disposition to issuerStock Options · Derivative | 40,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · derivative · entry 6 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 40,000 shares Expires 2034-06-18 F16 · kind: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F6 · derivative.exercise_date: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · derivative.underlying_shares: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · balance_after: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F6 · ownership.nature: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Disposition to issuerRestricted Stock Units · Derivative | 35,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · derivative · entry 5 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 35,538 shares Expires not disclosed F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F15 · kind: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · derivative.expiration_date: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. F4 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · balance_after: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3 · ownership.nature: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Disposition to issuerRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · derivative · entry 4 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 20,000 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F15 · kind: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F5 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3 · ownership.nature: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantStock Options · Derivative | 40,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001104659-24-073984 · tm2417785-1_4seq1.xml · derivative · entry 5 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 40,000 Underlying: Common stock, par value $0.0001 · 40,000 shares Expires 2034-06-18 F7 · kind: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F7 · derivative.exercise_date: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F7 · derivative.underlying_shares: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F7 · balance_after: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F7 · ownership.nature: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F12 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionRestricted Stock Units · Derivative | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-073984 · tm2417785-1_4seq1.xml · derivative · entry 4 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F4 · kind: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F5 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F5 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,293,624 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,562,080 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F12 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073984 · tm2417785-1_4seq1.xml · derivative · entry 2 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 55,538 Underlying: Common stock, par value $0.0001 · 20,000 shares Expires not disclosed F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · kind: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,293,624 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,562,080 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F12 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionCommon stock, par value $0.0001 per share | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-073984 · tm2417785-1_4seq1.xml · nonDerivative · entry 1 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 15,855,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Persons. F5 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F8 · balance_after: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. F9 · balance_after: As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F10 · balance_after: Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,293,624 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,562,080 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F12 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. F14 · ownership.nature: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. Read SEC document |
| November 01, 2023 Filed Nov 14, 2023 21:47 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionRestricted Stock Units · Derivative | 17,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-118341 · tm2330765-1_4seq1.xml · derivative · entry 2 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 35,538 Underlying: Common stock, par value $0.0001 · 17,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F3 · kind: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Persons. F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · derivative.expiration_date: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F4 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · balance_after: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,283,484 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,534,450 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| November 01, 2023 Filed Nov 14, 2023 21:47 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionCommon stock, par value $0.0001 per share | 17,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-118341 · tm2330765-1_4seq1.xml · nonDerivative · entry 1 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 15,835,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Persons. F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F7 · balance_after: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. F8 · balance_after: As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F9 · balance_after: Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,283,484 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,534,450 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. F13 · ownership.nature: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 21:46 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantStock Options · Derivative | 40,000 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001104659-23-075413 · tm2319845-1_4seq1.xml · derivative · entry 5 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 40,000 Underlying: Common stock, par value $0.0001 · 40,000 shares Expires 2033-06-23 F6 · derivative.exercise_date: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · derivative.underlying_shares: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · balance_after: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F6 · ownership.nature: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F10 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 21:46 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-075413 · tm2319845-1_4seq1.xml · derivative · entry 4 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 20,000 Underlying: Common stock, par value $0.0001 · 20,000 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,283,484 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,534,450 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F10 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 20:54 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantCommon stock, par value $0.0001 per share | 53,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001606 · tm232303-1_4seq1.xml · nonDerivative · entry 1 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 15,871,242 F5 · kind: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F5 · shares: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F3 · balance_after: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), F4 · balance_after: and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,283,484 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,534,450 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F6 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherWarrants · Derivative | 6,121,375 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · derivative · entry 7 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,121,375 Underlying: Common stock, par value $0.0001 · 6,121,375 shares Expires 2027-11-01 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F9 · shares: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · shares: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · price: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · price: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · derivative.exercise_date: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · derivative.exercise_date: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F5 · ownership.nature: Directly owned by ACP V Offshore. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherWarrants · Derivative | 5,224,114 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · derivative · entry 6 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 5,224,114 Underlying: Common stock, par value $0.0001 · 5,224,114 shares Expires 2027-11-01 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F9 · shares: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · shares: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · price: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · price: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · derivative.exercise_date: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · derivative.exercise_date: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F4 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherWarrants · Derivative | 11,345,489 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · derivative · entry 5 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 11,345,489 shares Expires 2027-11-01 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F9 · shares: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · shares: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · price: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · price: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · derivative.exercise_date: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · derivative.exercise_date: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherCommon stock, par value $0.0001 per share | 8,534,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · nonDerivative · entry 3 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 8,534,450 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F3 · price: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F6 · balance_after: In accordance with the letter agreement, dated March 23, 2022, among the Issuer, Avista Sponsor, Legacy OmniAb and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. As a result of the transactions described in this Form 4, and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F7 · balance_after: Additionally, in connection with the transactions described in this Form 4, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F5 · ownership.nature: Directly owned by ACP V Offshore. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherCommon stock, par value $0.0001 per share | 7,283,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · nonDerivative · entry 2 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 7,283,484 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F3 · price: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F6 · balance_after: In accordance with the letter agreement, dated March 23, 2022, among the Issuer, Avista Sponsor, Legacy OmniAb and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. As a result of the transactions described in this Form 4, and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F7 · balance_after: Additionally, in connection with the transactions described in this Form 4, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F4 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherCommon stock, par value $0.0001 per share | 15,817,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · nonDerivative · entry 1 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F3 · price: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:37 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantStock Option · Derivative | 161,849 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000899243-22-037741 · doc4.xml · derivative · entry 2 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 161,849 Underlying: Common Stock · 161,849 shares Expires 2032-12-01 F3 · shares: Represents a stock option granted on December 1, 2022 to Joshua Tamaroff in his position as a Director of the Issuer, which vests in three substantially similar annual installments beginning on November 1, 2023. Mr. Tamaroff is a partner at Avista Capital Partners and has assigned all rights, title and interest in the stock option to the Avista Affiliates. The Avista Affiliates are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Reporting Persons may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F3 · derivative.exercise_date: Represents a stock option granted on December 1, 2022 to Joshua Tamaroff in his position as a Director of the Issuer, which vests in three substantially similar annual installments beginning on November 1, 2023. Mr. Tamaroff is a partner at Avista Capital Partners and has assigned all rights, title and interest in the stock option to the Avista Affiliates. The Avista Affiliates are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Reporting Persons may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista GP"), which is the general partner of Avista Sponsor, and Thompson Dean and David Burgstahler, who are the managers of Avista GP (together with Avista Sponsor and Avista GP, the "Avista Affiliates"), and Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Represents a stock option granted on December 1, 2022 to Joshua Tamaroff in his position as a Director of the Issuer, which vests in three substantially similar annual installments beginning on November 1, 2023. Mr. Tamaroff is a partner at Avista Capital Partners and has assigned all rights, title and interest in the stock option to the Avista Affiliates. The Avista Affiliates are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Reporting Persons may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 19:00 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantWarrants · Derivative | 11,345,489 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-114525 · tm2229290-1_4seq1.xml · derivative · entry 2 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 11,345,489 Underlying: Common stock, par value $0.0001 · 11,345,489 shares Expires 2027-11-01 F5 · shares: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F6 · shares: In connection with the A&R Forward Purchase Agreement, Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F5 · price: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F6 · price: In connection with the A&R Forward Purchase Agreement, Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F5 · derivative.exercise_date: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F6 · derivative.exercise_date: In connection with the A&R Forward Purchase Agreement, Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista GP"), which is the general partner of Avista, and Thompson Dean and David Burgstahler, who are the managers of Avista GP. Because of the relationships among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F2 · ownership.nature: Directly owned by Avista Sponsor. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 19:00 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantCommon stock, par value $0.0001 per share | 10,172,934 | $10.00 | $101,729,340.00 |
DisclosureSEC source: 0001104659-22-114525 · tm2229290-1_4seq1.xml · nonDerivative · entry 1 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 15,817,934 F3 · shares: Avista Sponsor acquired the shares of common stock of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer") in accordance with the Agreement and Plan of Merger, dated as of March 23, 2022 (the "Merger Agreement"), by and among the Issuer, Ligand Pharmaceuticals Incorporated, OmniAb, Inc. ("Legacy OmbiAb"), and Orwell Merger Sub Inc. and the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and Legacy OmniAb (the "A&R Forward Purchase Agreement"). F4 · balance_after: In accordance with the letter agreement, dated March 23, 2022, among the Issuer, Avista Sponsor, Legacy OmniAb and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista GP"), which is the general partner of Avista, and Thompson Dean and David Burgstahler, who are the managers of Avista GP. Because of the relationships among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F2 · ownership.nature: Directly owned by Avista Sponsor. Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:45 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A common stock | 21,154,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-017951 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 7,721,298 F2 · shares: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution"). F3 · shares: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution. F2 · price: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution"). F3 · balance_after: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 24, 2020 Filed Nov 24, 2020 18:10 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 100 | $5.00 | $500.00 |
DisclosureSEC source: 0001140361-20-026482 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,924,515 F5 · shares: Represents an aggregate of 50 shares of Common Stock purchased by ACP Onshore and 50 shares of Common Stock purchased by ACP Offshore. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 18:10 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 2,739 | $4.99 | $13,670.62 |
DisclosureSEC source: 0001140361-20-026482 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,924,415 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 1,373 shares of Common Stock purchased by ACP Onshore and 1,366 shares of Common Stock purchased by ACP Offshore. F4 · price: Purchase prices range from $4.98 to $5.00 per share, inclusive. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests Read SEC document |
| November 19, 2020 Filed Nov 19, 2020 19:14 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 36,127 | $4.97 | $179,612.61 |
DisclosureSEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 4 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,921,676 F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F9 · shares: Represents an aggregate of 18,111 shares of Common Stock purchased by ACP Onshore and 18,016 shares of Common Stock purchased by ACP Offshore. F10 · price: Purchase prices range from $4.86 to $5.00 per share, inclusive. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 18, 2020 Filed Nov 19, 2020 19:14 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 45,378 | $4.68 | $212,518.79 |
DisclosureSEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 3 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,885,549 F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · shares: Represents an aggregate of 22,747 shares of Common Stock purchased by ACP Onshore and 22,631 shares of Common Stock purchased by ACP Offshore. F8 · price: Purchase prices range from $4.58 to $4.75 per share, inclusive. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:14 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 50,000 | $4.45 | $222,405.00 |
DisclosureSEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,840,171 F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F5 · shares: Represents an aggregate of 25,065 shares of Common Stock purchased by ACP Onshore and 24,935 shares of Common Stock purchased by ACP Offshore. F6 · price: Purchase prices range from $4.38 to $4.50 per share, inclusive. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:14 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 4,272,657 | $3.25 | $13,886,135.25 |
DisclosureSEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,790,171 F2 · shares: Represents an aggregate of 2,142,071 shares of Class A common stock of the Issuer ("Common Stock") purchased by ACP Onshore and 2,130,586 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 17, 2020. F3 · price: Represents the public offering price of $3.25 per share of Common Stock, without giving effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of the Avista Funds ("Avista Management"), pursuant to the Fee Letter Agreement, dated November 12, 2020, among the Issuer, Avista Management and the Avista Funds, made in connection with the Offering, as described in the Issuer's Current Report on Form 8-K filed on November 18, 2020 and filed as Exhibit 10.1 thereto. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 16, 2020 Filed Mar 16, 2020 21:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 75,000 | $3.98 | $298,132.50 |
DisclosureSEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 4 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 25,517,514 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F12 · shares: Represents an aggregate of 37,601 shares of Common Stock purchased by ACP Onshore and 37,399 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F13 · price: Purchase prices range from $3.67 to $4.29 per share, inclusive. F14 · balance_after: Represents 12,267,300 shares of Common Stock owned directly by ACP Onshore, 12,201,523 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 21:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 135,000 | $4.31 | $581,283.00 |
DisclosureSEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 3 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 25,442,514 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F9 · shares: Represents an aggregate of 67,681 shares of Common Stock purchased by ACP Onshore and 67,319 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F10 · price: Purchase prices range from $4.02 to $4.47 per share, inclusive. F11 · balance_after: Represents 12,229,699 shares of Common Stock owned directly by ACP Onshore, 12,164,124 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 21:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 141,462 | $4.17 | $590,377.51 |
DisclosureSEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 25,307,514 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F6 · shares: Represents an aggregate of 70,921 shares of Common Stock purchased by ACP Onshore and 70,541 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · price: Purchase prices range from $3.975 to $4.50 per share, inclusive. F8 · balance_after: Represents 12,162,018 shares of Common Stock owned directly by ACP Onshore, 12,096,805 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 21:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 190,887 | $3.62 | $691,163.65 |
DisclosureSEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 25,166,052 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 95,700 shares of Common Stock purchased by ACP Onshore and 95,187 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $2.98 to $3.97 per share, inclusive. F5 · balance_after: Represents 12,091,097 shares of Common Stock owned directly by ACP Onshore, 12,026,264 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 16:17 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 6,000,000 | $5.00 | $30,000,000.00 |
DisclosureSEC source: 0001140361-19-021634 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 24,975,165 F2 · shares: Represents an aggregate of 3,008,064 shares of Common Stock purchased by ACP Onshore and 2,991,936 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 26, 2019. F3 · price: Represents the public offering price of $5.00 per share of Common Stock, without giving effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of the Avista Funds ("Avista Management"), pursuant to the Fee Letter Agreement, dated November 19, 2019, among the Issuer, Avista Management and the Avista Funds, made in connection with the Offering, as described in the Issuer's Current Report on Form 8-K filed on November 22, 2019 and filed as Exhibit 10.1 thereto. F2 · balance_after: Represents an aggregate of 3,008,064 shares of Common Stock purchased by ACP Onshore and 2,991,936 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 26, 2019. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore" and together with ACP Onshore, the "Avista Funds"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 18:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 413,900 | $6.25 | $2,585,343.57 |
DisclosureSEC source: 0001140361-19-016669 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,975,165 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F6 · shares: Represents an aggregate of 207,507 shares of Common Stock purchased by ACP Onshore and 206,393 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · price: Purchase prices range from $5.62 to $6.25 per share, inclusive. F8 · balance_after: Represents 8,987,333 shares of Common Stock owned directly by ACP Onshore, 8,939,141 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F9 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F10 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 11, 2019 Filed Sep 13, 2019 18:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 447,000 | $5.75 | $2,570,428.80 |
DisclosureSEC source: 0001140361-19-016669 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,561,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 224,101 shares of Common Stock purchased by ACP Onshore and 222,899 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $5.365 to $5.905 per share, inclusive. F5 · balance_after: Represents 8,779,826 shares of Common Stock owned directly by ACP Onshore, 8,732,748 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F9 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F10 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 10, 2019 Filed Sep 10, 2019 19:56 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 12,000 | $5.18 | $62,206.80 |
DisclosureSEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 3 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,114,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F9 · shares: Represents an aggregate of 6,016 shares of Common Stock purchased by ACP Onshore and 5,984 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F10 · price: Purchase prices range from $4.99 to $5.25 per share, inclusive. F11 · balance_after: Represents 8,555,725 shares of Common Stock owned directly by ACP Onshore, 8,509,849 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 09, 2019 Filed Sep 10, 2019 19:56 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 25,000 | $5.12 | $128,022.50 |
DisclosureSEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,102,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F6 · shares: Represents an aggregate of 12,534 shares of Common Stock purchased by ACP Onshore and 12,466 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · price: Purchase prices range from $4.91 to $5.68 per share, inclusive. F8 · balance_after: Represents 8,549,709 shares of Common Stock owned directly by ACP Onshore, 8,503,865 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 19:56 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 500,000 | $5.18 | $2,592,300.00 |
DisclosureSEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,077,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 250,673 shares of Common Stock purchased by ACP Onshore and 249,327 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $4.73 to $5.35 per share, inclusive. F5 · balance_after: Represents 8,537,175 shares of Common Stock owned directly by ACP Onshore, 8,491,399 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 05, 2019 Filed Sep 5, 2019 18:51 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 177,600 | $4.89 | $868,570.56 |
DisclosureSEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 3 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 17,577,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F9 · shares: Represents an aggregate of 89,039 shares of Common Stock purchased by ACP Onshore and 88,561 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F10 · price: Purchase prices range from $4.52 to $4.90 per share, inclusive. F11 · balance_after: Represents 8,286,502 shares of Common Stock owned directly by ACP Onshore, 8,242,072 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:51 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 200,000 | $4.90 | $979,220.00 |
DisclosureSEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 17,399,665 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F6 · shares: Represents an aggregate of 100,269 shares of Common Stock purchased by ACP Onshore and 99,731 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · price: Purchase prices range from $4.70 to $4.90 per share, inclusive. F8 · balance_after: Represents 8,197,463 shares of Common Stock owned directly by ACP Onshore, 8,153,511 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:51 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 200,000 | $4.75 | $949,760.00 |
DisclosureSEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 17,199,665 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 100,269 shares of Common Stock purchased by ACP Onshore and 99,731 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $4.44 to $4.75 per share, inclusive. F5 · balance_after: Represents 8,097,194 shares of Common Stock owned directly by ACP Onshore, 8,053,780 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 17:05 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | Disposition to issuerWarrants (right to buy) · Derivative | 4,100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-19-015434 · form4.xml · derivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Class A common stock · 2,050,000 shares Expires 2023-12-10 F5 · derivative.exercise_price: Each warrant entitled the holder to purchase from the Issuer shares of Common Stock at a price of $5.75 per-half share of Common Stock (or $11.50 per whole share), subject to adjustments. F2 · kind: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange"). F2 · price: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange"). F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thomspon Dean; and David Burgstahler. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 17:05 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A common stock | 389,501 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-19-015434 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 16,999,665 F2 · kind: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange"). F2 · price: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange"). F3 · balance_after: Represents 7,996,925 shares of Common Stock owned directly by ACP Onshore and 7,954,049 shares of Common Stock owned directly by ACP Offshore, in each case, following the Warrant Exchange, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F4 · balance_after: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests.Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thomspon Dean; and David Burgstahler. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:39 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantWarrants · Derivative | 4,100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-045047 · form4.xml · derivative · entry 4 Burgstahler David F · CIK 0001374179 · Director · President & CEO · 10% owner Dean Thompson · CIK 0001069096 · Director · Executive Chairman · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 4,100,000 Underlying: Class A Common Stock · 2,050,000 shares Expires 2023-12-10 F7 · derivative.exercise_price: Each warrant entitles the holder to purchase from the Issuer the number of shares of Class A common stock at the price of $5.75 per half-share (or $11.50 per whole share), subject to adjustments. F2 · kind: The Reporting Persons acquired indirectly in a private placement from Avista Healthcare Public Acquisition Corp. (prior to the Issuer's Business Combination) an aggregate of 9,022,741 shares of Class A common stock, including 4,523,497 shares owned through Fund IV and 4,499,244 shares owned through Offshore Fund IV, and an aggregate of 4,100,000 warrants to purchase shares of Class A common stock, including 2,055,510 warrants to purchase 1,027,755 shares through Fund IV and 2,044,490 warrants to purchase 1,022,245 shares owned through Offshore Fund IV warrants to purchase one-half of one share of Class A common stock for an aggregate purchase price of $46,000,000. F2 · shares: The Reporting Persons acquired indirectly in a private placement from Avista Healthcare Public Acquisition Corp. (prior to the Issuer's Business Combination) an aggregate of 9,022,741 shares of Class A common stock, including 4,523,497 shares owned through Fund IV and 4,499,244 shares owned through Offshore Fund IV, and an aggregate of 4,100,000 warrants to purchase shares of Class A common stock, including 2,055,510 warrants to purchase 1,027,755 shares through Fund IV and 2,044,490 warrants to purchase 1,022,245 shares owned through Offshore Fund IV warrants to purchase one-half of one share of Class A common stock for an aggregate purchase price of $46,000,000. F2 · price: The Reporting Persons acquired indirectly in a private placement from Avista Healthcare Public Acquisition Corp. (prior to the Issuer's Business Combination) an aggregate of 9,022,741 shares of Class A common stock, including 4,523,497 shares owned through Fund IV and 4,499,244 shares owned through Offshore Fund IV, and an aggregate of 4,100,000 warrants to purchase shares of Class A common stock, including 2,055,510 warrants to purchase 1,027,755 shares through Fund IV and 2,044,490 warrants to purchase 1,022,245 shares owned through Offshore Fund IV warrants to purchase one-half of one share of Class A common stock for an aggregate purchase price of $46,000,000. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: David Burgstahler and Thompson Dean. Messrs. Burgstahler and Dean are managers of Avista Acquisition LLC, the sole shareholder of Avista Acquisition Corp. (the "Sponsor"), and are members of the investment committee of Avista Capital Partners IV GP, L.P., the general partner of Avista Capital Partners IV, L.P. ("Fund IV") and Avista Capital Partners (Offshore) IV, L.P. ("Offshore Fund IV"), and each has veto rights over the voting and disposition of the securities of the Issuer. F8 · ownership.nature: Because of the relationship between the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:39 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | Disposition to issuerClass B ordinary shares · Derivative | 3,247,668 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-045047 · form4.xml · derivative · entry 3 Burgstahler David F · CIK 0001374179 · Director · President & CEO · 10% owner Dean Thompson · CIK 0001069096 · Director · Executive Chairman · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 1,048,691 Underlying: Class A Ordinary Shares · 3,247,668 shares Expires not disclosed F5 · derivative.exercise_price: Pursuant to the Amended and Restated Memorandum and Articles of Association (the "Articles") of the Issuer, the Class B ordinary shares, par value $0.0001 per share (the "Class B Shares") will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's Business Combination, as defined in the Articles, on a one-for-one basis, subject to adjustment, and have no expiration date. F6 · kind: The 3,247,668 Class B Shares were indirectly forfeited by the Reporting Persons to the Issuer through Sponsor for no consideration prior to the closing of the Business Combination. F6 · shares: The 3,247,668 Class B Shares were indirectly forfeited by the Reporting Persons to the Issuer through Sponsor for no consideration prior to the closing of the Business Combination. F6 · price: The 3,247,668 Class B Shares were indirectly forfeited by the Reporting Persons to the Issuer through Sponsor for no consideration prior to the closing of the Business Combination. F5 · derivative.exercise_date: Pursuant to the Amended and Restated Memorandum and Articles of Association (the "Articles") of the Issuer, the Class B ordinary shares, par value $0.0001 per share (the "Class B Shares") will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's Business Combination, as defined in the Articles, on a one-for-one basis, subject to adjustment, and have no expiration date. F5 · derivative.expiration_date: Pursuant to the Amended and Restated Memorandum and Articles of Association (the "Articles") of the Issuer, the Class B ordinary shares, par value $0.0001 per share (the "Class B Shares") will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's Business Combination, as defined in the Articles, on a one-for-one basis, subject to adjustment, and have no expiration date. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: David Burgstahler and Thompson Dean. Messrs. Burgstahler and Dean are managers of Avista Acquisition LLC, the sole shareholder of Avista Acquisition Corp. (the "Sponsor"), and are members of the investment committee of Avista Capital Partners IV GP, L.P., the general partner of Avista Capital Partners IV, L.P. ("Fund IV") and Avista Capital Partners (Offshore) IV, L.P. ("Offshore Fund IV"), and each has veto rights over the voting and disposition of the securities of the Issuer. F8 · ownership.nature: Because of the relationship between the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:39 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A common stock | 6,538,732 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-045047 · form4.xml · nonDerivative · entry 2 Burgstahler David F · CIK 0001374179 · Director · President & CEO · 10% owner Dean Thompson · CIK 0001069096 · Director · Executive Chairman · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 15,561,473 F3 · kind: The Reporting Persons acquired indirectly 3,278,154 shares of Class A common stock through Fund IV and 3,260,578 shares of Class A common stock through Offshore Fund IV, in each case, at an exchange ratio of 2.03 shares of the Issuer's Class A common stock for each share of common stock of Organogenesis Inc. in connection with the consummation of the business combination pursuant to that certain Agreement and Plan of Merger, dated as of August 17, 2018, by and among the Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis Inc. F3 · price: The Reporting Persons acquired indirectly 3,278,154 shares of Class A common stock through Fund IV and 3,260,578 shares of Class A common stock through Offshore Fund IV, in each case, at an exchange ratio of 2.03 shares of the Issuer's Class A common stock for each share of common stock of Organogenesis Inc. in connection with the consummation of the business combination pursuant to that certain Agreement and Plan of Merger, dated as of August 17, 2018, by and among the Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis Inc. F4 · balance_after: Represents 7,801,651 shares of Class A common stock indirectly owned by the Reporting Persons through Fund IV and 7,759,802 shares of Class A common stock indirectly owned by the Reporting Persons through Offshore Fund IV. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: David Burgstahler and Thompson Dean. Messrs. Burgstahler and Dean are managers of Avista Acquisition LLC, the sole shareholder of Avista Acquisition Corp. (the "Sponsor"), and are members of the investment committee of Avista Capital Partners IV GP, L.P., the general partner of Avista Capital Partners IV, L.P. ("Fund IV") and Avista Capital Partners (Offshore) IV, L.P. ("Offshore Fund IV"), and each has veto rights over the voting and disposition of the securities of the Issuer. F8 · ownership.nature: Because of the relationship between the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:39 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A common stock | 9,022,741 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-045047 · form4.xml · nonDerivative · entry 1 Burgstahler David F · CIK 0001374179 · Director · President & CEO · 10% owner Dean Thompson · CIK 0001069096 · Director · Executive Chairman · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 9,022,741 F2 · kind: The Reporting Persons acquired indirectly in a private placement from Avista Healthcare Public Acquisition Corp. (prior to the Issuer's Business Combination) an aggregate of 9,022,741 shares of Class A common stock, including 4,523,497 shares owned through Fund IV and 4,499,244 shares owned through Offshore Fund IV, and an aggregate of 4,100,000 warrants to purchase shares of Class A common stock, including 2,055,510 warrants to purchase 1,027,755 shares through Fund IV and 2,044,490 warrants to purchase 1,022,245 shares owned through Offshore Fund IV warrants to purchase one-half of one share of Class A common stock for an aggregate purchase price of $46,000,000. F2 · price: The Reporting Persons acquired indirectly in a private placement from Avista Healthcare Public Acquisition Corp. (prior to the Issuer's Business Combination) an aggregate of 9,022,741 shares of Class A common stock, including 4,523,497 shares owned through Fund IV and 4,499,244 shares owned through Offshore Fund IV, and an aggregate of 4,100,000 warrants to purchase shares of Class A common stock, including 2,055,510 warrants to purchase 1,027,755 shares through Fund IV and 2,044,490 warrants to purchase 1,022,245 shares owned through Offshore Fund IV warrants to purchase one-half of one share of Class A common stock for an aggregate purchase price of $46,000,000. F2 · balance_after: The Reporting Persons acquired indirectly in a private placement from Avista Healthcare Public Acquisition Corp. (prior to the Issuer's Business Combination) an aggregate of 9,022,741 shares of Class A common stock, including 4,523,497 shares owned through Fund IV and 4,499,244 shares owned through Offshore Fund IV, and an aggregate of 4,100,000 warrants to purchase shares of Class A common stock, including 2,055,510 warrants to purchase 1,027,755 shares through Fund IV and 2,044,490 warrants to purchase 1,022,245 shares owned through Offshore Fund IV warrants to purchase one-half of one share of Class A common stock for an aggregate purchase price of $46,000,000. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: David Burgstahler and Thompson Dean. Messrs. Burgstahler and Dean are managers of Avista Acquisition LLC, the sole shareholder of Avista Acquisition Corp. (the "Sponsor"), and are members of the investment committee of Avista Capital Partners IV GP, L.P., the general partner of Avista Capital Partners IV, L.P. ("Fund IV") and Avista Capital Partners (Offshore) IV, L.P. ("Offshore Fund IV"), and each has veto rights over the voting and disposition of the securities of the Issuer. F8 · ownership.nature: Because of the relationship between the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.